Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
Vaccine|June 2, 1998
Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis ratsK S Ariail, B F Bebo, K Adlard, et al.Marine Pollution Bulletin|June 23, 2009
Effects of age, sex and reproductive status on persistent organic pollutant concentrations in "Southern Resident" killer whalesMargaret M Krahn, M Bradley Hanson, Gregory S Schorr, et al.European Journal of Immunology|April 29, 2004
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic miceCathleen Rich, Jason M Link, Alex Zamora, et al.Journal of Neuroscience Research|June 14, 2005
Decreased FOXP3 levels in multiple sclerosis patientsJianya Huan, Nicole Culbertson, Leslie Spencer, et al.Journal of Neurochemistry|August 11, 2006
Antigen-specific therapy promotes repair of myelin and axonal damage in established EAEChunhe Wang, Bruce G Gold, Laurie J Kaler, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 16, 2007
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNSSushmita Sinha, Sandhya Subramanian, Thomas M Proctor, et al.European Journal of Immunology|April 7, 2011
TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexesRony Dahan, Moran Tabul, Yuan K Chou, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 1, 2009
Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGSushmita Sinha, Sandhya Subramanian, Ashley Emerson-Webber, et al.Metabolic Brain Disease|April 8, 2011
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in miceSuzan Dziennis, Sarah Mader, Kozaburo Akiyoshi, et al.Journal of Neuroimmunology|June 16, 2010
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitisSushmita Sinha, Lisa Miller, Sandhya Subramanian, et al.Pageof 15